- Home
- NWFL vs TVRD Comparison
NWFL vs TVRD Comparison
Compare NWFL & TVRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWFL
- TVRD
- Stock Information
- Founded
- NWFL 1870
- TVRD 2017
- Country
- NWFL United States
- TVRD United States
- Employees
- NWFL N/A
- TVRD N/A
- Industry
- NWFL Major Banks
- TVRD Biotechnology: Pharmaceutical Preparations
- Sector
- NWFL Finance
- TVRD Health Care
- Exchange
- NWFL Nasdaq
- TVRD Nasdaq
- Market Cap
- NWFL 208.5M
- TVRD 246.5M
- IPO Year
- NWFL 1998
- TVRD N/A
- Fundamental
- Price
- NWFL $25.92
- TVRD $29.76
- Analyst Decision
- NWFL Buy
- TVRD Strong Buy
- Analyst Count
- NWFL 3
- TVRD 2
- Target Price
- NWFL $28.17
- TVRD $52.00
- AVG Volume (30 Days)
- NWFL 15.7K
- TVRD 45.2K
- Earning Date
- NWFL 07-25-2025
- TVRD 05-13-2025
- Dividend Yield
- NWFL 4.74%
- TVRD N/A
- EPS Growth
- NWFL N/A
- TVRD N/A
- EPS
- NWFL 0.14
- TVRD N/A
- Revenue
- NWFL $50,378,000.00
- TVRD N/A
- Revenue This Year
- NWFL $79.38
- TVRD N/A
- Revenue Next Year
- NWFL $7.19
- TVRD N/A
- P/E Ratio
- NWFL $184.66
- TVRD N/A
- Revenue Growth
- NWFL N/A
- TVRD N/A
- 52 Week Low
- NWFL $21.25
- TVRD $8.13
- 52 Week High
- NWFL $34.50
- TVRD $34.31
- Technical
- Relative Strength Index (RSI)
- NWFL 52.97
- TVRD N/A
- Support Level
- NWFL $25.22
- TVRD N/A
- Resistance Level
- NWFL $26.32
- TVRD N/A
- Average True Range (ATR)
- NWFL 0.55
- TVRD 0.00
- MACD
- NWFL -0.11
- TVRD 0.00
- Stochastic Oscillator
- NWFL 37.23
- TVRD 0.00
About NWFL Norwood Financial Corp.
Norwood Financial Corp is a U.S.-based bank holding company. It offers various personal and business credit services, trust and investment products, and real estate settlement services to consumers, businesses, nonprofit organizations, and municipalities in each of the communities that the bank serves. The bank also manages automated teller machines at its branch location. It serves the Pennsylvanian counties of Wayne, Pike, Monroe, and Lackawanna, as well as Susquehanna County.
About TVRD Tvardi Therapeutics Inc. Common Stock
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.